BookL. Harivardhan Reddy, Patrick Couvreur, editors ; foreword by Rakesh K. Jain.
Contents:
Part 1. Classification, Opportunities and Challenges
Classification of Anticancer Drugs Based on Therapeutic Targets
Signal Transduction Pathways as Therapeutic Targets in Cancer Therapy
Part 2. Polymer-Based Anticancer Prodrugs
HPMA-Anticancer Drug Conjugates
Poly-l-Glutamic Acid Anti-cancer Drug Conjugates
Polysaccharide-Based Anticancer Prodrugs
PEG-Anticancer Drugs
Poly(ethylene glycol)-Protein, Peptide, and Enzyme Conjugates
Part 3. Lipid-Based
Anticancer Prodrugs
Lipid-Based Anticancer Prodrugs
Part 4. Antibody-Directed Cancer Therapy
Antibody-Cytotoxic Compound Conjugates for Oncology
Immunoconjugate Anticancer Therapeutics
Antibody-Directed Enzyme Prodrug Therapy (ADEPT) for Cancer
EGFR-Directed Monoclonal Antibodies
The Biology of the HER Family and Her2/neu Directed-Antibody Therapy
Anti-Vascular Endothelial Growth Factor Monoclonal Antibodies
Monoclonal Antibody Therapy for Hematologic Malignancies
Part 5. Anticancer Oligonucleotide Therapeutics
Anticancer Oligonucleotides
Part 6. Miscellaneous
New Molecular Therapeutic Interventions: The Case of Breast Cancers.